The arrest warrant for Jang Won-jun, former CEO of Shin Poong Pharmaceutical, is dismissed

COMPANY / Reporter Paul Lee / 2023-01-29 23:55:26
This article is translated by AI company Flitto and Alhpa Biz neural machine translation technology
(사진=연합뉴스)

[Alpha Biz=(Chicago) Reporter Paul Lee] An arrest warrant for former CEO of Shinpoong Pharmaceutical Co., who was accused of raising slush funds worth 5.7 billion won through false transactions with customers and inflating unit prices, was rejected by the court.

Kim Jung-min, a senior judge in charge of warrants at the Seoul Central District Court, on the 27th rejected the request for former CEO Jang Won-joon's arrest warrant filed by the prosecution on charges of violating the Act on External Audit of Stock Companies, saying, "It is hard to say that there is a fear of destroying evidence."

Former CEO Jang Won-joon is suspected of colluding with Executive Director A of Shinpoong Pharmaceutical to create a slush fund worth 5.7 billion won by returning the difference after a fake transaction with Company B, a pharmaceutical raw material company, from April 2011 to March 2018. It is also suspected of falsely preparing and disclosing Shinpoong Pharmaceutical's financial statements.

Meanwhile, executive director A was first put on trial under arrest last month, and former Shinpoong Pharmaceutical Chairman Jang Yong-taek, who was involved in the allegations, died and was treated as having no right to indict.

Alphabiz Reporter Paul Lee(hoondork@alphabiz.co.kr)

어플

주요기사

Bithumb Faces ‘Book-Entry Trading’ Concerns After Miscrediting Hundreds of Thousands of Bitcoins
Kolmar Korea Certified as Year’s First ‘Reshoring’ Company; To Invest 100 Billion KRW in Smart Factory Expansion
Court Dismisses Additional Lawsuits by Shareholders Over "Invossa" Controversy, Ruling in Favor of Kolon
Nvidia Delays China H200 Chip Exports Amid Ongoing Talks With U.S. Government
Naver Issues Formal Apology Over Exposure of Celebrities’ and Politicians’ Past "Ji-sik-iN" Posts
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS